Bonanza for drug companies. Quebec's public drug plan pays for biotechnology boom.
作者信息
Blair Louisa
出版信息
Can Fam Physician. 2002 Apr;48:831, 833, 836-8.
Abstract
摘要
相似文献
1
Bonanza for drug companies. Quebec's public drug plan pays for biotechnology boom.
Can Fam Physician. 2002 Apr;48:831, 833, 836-8.
2
Industry warily eyes new Medicare drug plan.
Nat Biotechnol. 2006 Feb;24(2):120. doi: 10.1038/nbt0206-120.
3
The draft pharmaceutical policy: the weakest link.
Perspect Infirm. 2005 Mar-Apr;2(4):8-11.
4
A catastrophe in health care.
Can Nurse. 2009 Nov;105(9):52.
5
Democracy unleashed--unpacking the tooth fairy in drug industry R&D.
Nat Biotechnol. 2006 Nov;24(11):1324-6; author reply 1326-7. doi: 10.1038/nbt1106-1324.
6
Evaluating the effects of Quebec's private-public drug insurance system.
CMAJ. 2017 Oct 10;189(40):E1259-E1263. doi: 10.1503/cmaj.170726.
7
India: 50 years after independence.
Nat Biotechnol. 1997 Aug;15(8):727-9. doi: 10.1038/nbt0897-727.
8
Product listing agreements (PLAs): a new tool for reaching Quebec's pharmaceutical policy objectives?
Healthc Policy. 2013 Aug;9(1):65-75.
9
Disease management. Getting out from under drug companies' shadows.
Manag Care. 2000 Mar;9(3):39-40, 42-3.
10
"Tough but fair"? The active management of the New Zealand drug benefits scheme by an independent Crown agency.
Aust Health Rev. 2004 Nov 8;28(2):171-81. doi: 10.1071/ah040171.
Zotero 插件